TẾ BÀO GỐC - BÍ MẬT CỦA SUỐI NGUỒN TƯƠI TRẺ - Trang 282

26. Perin EC, Dohmann HF, Borojevic, R et al. Transendocardial,

autologous bone marrow cell transplantation for severe, chronic ischemic heart
failure. Circulation. 2003; 107(18): 2294-2302.

27. Mathiasen AB, Qayyum AA, Jørgensen E, et al. Bone marrow-derived

mesenchymal stromal cell treatment in patients with severe ischaemic heart
failure: A randomized placebo-controlled trial (MSC-HF trial). Eur Heart J. 2015;
36(27): 1744-1753. doi: 10.1093/eurheartj/ehv136.

28. Patel AN, Geffner L, Vina RF, et al. Surgical treatment for congestive

heart failure with autologous adult stem cell transplantation: A prospective
randomized study. J Torac Cardiovasc Surg. 2005; 130(6): 1631-1638.e2.

29. Pätilä T, Lehtinen M, Vento A, et al. Autologous bone marrow

mononuclear cell transplantation in ischemic heart failure: A prospective,
controlled, randomized, double-blind study of cell transplantation combined with
coronary bypass. J Heart Lung Transplant. 2014; 33(6): 567-574. doi:
10.1016/j.healun.2014.02.009.

30. Falanga V, Iwamoto S, Chartier M, et al. Autologous bone Marrow–

Derived cultured Mesenchymal stem cells delivered in a fibrin spray accelerate
healing in murine and human cutaneous wounds. Tissue Eng. 2007; 13(6): 1299-
1312.

31. Yoshikawa T, Mitsuno H, Nonaka I, et al. Wound therapy by marrow

mesenchymal cell transplantation. Plast Reconstr Surg. 2008; 121(3): 860-877.
doi: 10.1097/01.prs.0000299922.96006.24.

32. Jain P, Perakath B, Jesudason MR, Nayak S. The effect of autologous

bone marrow-derived cells on healing chronic lower extremity wounds: Results
of a randomized controlled study. Ostomy Wound Manage. 2011; 57: 38-44.

33. Sharma A, Gokulchandran N, Chopra G, et al. Administration of

autologous bone marrow-derived mononuclear cells in children with incurable
neurological disorders and injury is safe and improves their quality of life. Cell
Transplant. 2012; 21 Suppl1: S79-90. doi: 10.3727/096368912X633798.

34. Sharma A, Gokulchandran N, Sane H, et al. Autologous bone marrow

mononuclear cell therapy for autism: an open label proof of concept study. Stem